Locally advanced pancreatic cancer (LAPC) has several definitions but essentially is a
nonmetastasized pancreatic cancer, in which upfront resection is considered not beneficial …

Background Large pragmatic studies of patients who received 5-fluorouracil with leucovorin,
irinotecan, and oxaliplatin ([m] FOLFIRINOX) as initial treatment for localized pancreatic …

Objective The aim of the present systematic review was to collect, analyze, and critically
evaluate the role of irreversible electroporation (IRE) in locally advanced pancreatic cancer …

Simple Summary Due to the availability of effective combination chemotherapies such as
gemcitabine/nab-paclitaxel (GNP) or FOLFIRINOX, neoadjuvant treatment of borderline …

Abstract Background/Purpose We evaluated efficacy of neoadjuvant therapy with
gemcitabine and nab‐paclitaxel (GNP‐NAT) in borderline resectable pancreatic cancer (BR …

The effectiveness of neoadjuvant therapy (NAT) remains unclear in resectable pancreatic
cancer (PC) as compared with upfront surgery (US). The aim of this study was to investigate …

Background Pancreatic cancer (PC) is a highly aggressive and refractory disease, with
disappointing 5-year survival rates. Regarding the wide application of neoadjuvant …

Pancreatic ductal adenocarcinoma (PDAC) remains a lethal cancer with an urgent need for
better medical therapies. Efforts have been made to investigate the efficacy of …

Familiäres Pankreaskarzinom (S. e836): Hier wird erstmals definiert, welchen Angehörigen
von Patienten mit familiärem Pankreaskarzinom welche genetischen Untersuchungen zur …

Pancreatic ductal adenocarcinoma is the third leading cause of cancer-related death in the
United States. As one of the most lethal cancer types, the prognosis for patients diagnosed …